Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127772441 | 12777244 | 1 | I | 20050601 | 20050603 | 20160924 | 20160924 | PER | US-ASTRAZENECA-2005BM00229 | ASTRAZENECA | 22909.00 | DY | M | Y | 61.70000 | KG | 20160924 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127772441 | 12777244 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | Y | U | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | Q12H | |||||
| 127772441 | 12777244 | 2 | SS | BYDUREON | EXENATIDE | 1 | Subcutaneous | 0 | 2 | MG | /wk | ||||||||
| 127772441 | 12777244 | 3 | SS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | 0 | 25 | MG | QD | ||||||||
| 127772441 | 12777244 | 4 | C | VYTORIN | EZETIMIBESIMVASTATIN | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 127772441 | 12777244 | 5 | C | AVANDAMET | METFORMIN HYDROCHLORIDEROSIGLITAZONE MALEATE | 1 | Oral | 1/1000, TWO TIMES A DAY | 0 | ||||||||||
| 127772441 | 12777244 | 6 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 0 | 75 | MG | QD | ||||||||
| 127772441 | 12777244 | 7 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 0 | 25 | MG | BID | ||||||||
| 127772441 | 12777244 | 8 | C | FISH OIL | FISH OIL | 1 | Oral | EVERY DAY | 0 | ||||||||||
| 127772441 | 12777244 | 9 | C | ASA | ASPIRIN | 1 | Oral | 0 | 325 | MG | QD | ||||||||
| 127772441 | 12777244 | 10 | C | VITAMIN C | ASCORBIC ACID | 1 | Oral | 0 | 500 | MG | QD | ||||||||
| 127772441 | 12777244 | 11 | C | PICOLINATE | 2 | Oral | 0 | 200 | MG | QD | |||||||||
| 127772441 | 12777244 | 12 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 325 | MG | QD | ||||||||
| 127772441 | 12777244 | 13 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | QOD | ||||||||
| 127772441 | 12777244 | 14 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | 5 | MG | QD | ||||||||
| 127772441 | 12777244 | 15 | C | IRON | IRON | 1 | Oral | 325.0MG UNKNOWN | 0 | 325 | MG | TABLET | |||||||
| 127772441 | 12777244 | 16 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | Oral | DAILY | 0 | ||||||||||
| 127772441 | 12777244 | 17 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 0 | 100 | MG | QD | ||||||||
| 127772441 | 12777244 | 18 | C | OMEGA 3 | OMEGA-3 FATTY ACIDS | 1 | 0 | ||||||||||||
| 127772441 | 12777244 | 19 | C | LUTEIN | LUTEIN | 1 | Oral | 0 | 25 | MG | QD | ||||||||
| 127772441 | 12777244 | 20 | C | TRECOSE | 2 | Oral | 0 | 50 | MG | Q8H | |||||||||
| 127772441 | 12777244 | 21 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 0 | 20 | MG | QOD | ||||||||
| 127772441 | 12777244 | 22 | C | SODIUM BICARBONATE. | SODIUM BICARBONATE | 1 | Oral | 0 | 650 | MG | Q12H | ||||||||
| 127772441 | 12777244 | 23 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 0 | 75 | MG | QD | ||||||||
| 127772441 | 12777244 | 24 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 127772441 | 12777244 | 25 | C | MULTIVITAMIN | VITAMINS | 1 | Oral | DAILY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127772441 | 12777244 | 1 | Type 2 diabetes mellitus |
| 127772441 | 12777244 | 2 | Type 2 diabetes mellitus |
| 127772441 | 12777244 | 3 | Blood pressure abnormal |
| 127772441 | 12777244 | 4 | Blood cholesterol abnormal |
| 127772441 | 12777244 | 5 | Diabetes mellitus |
| 127772441 | 12777244 | 7 | Hypertension |
| 127772441 | 12777244 | 12 | Myocardial infarction |
| 127772441 | 12777244 | 13 | Myocardial infarction |
| 127772441 | 12777244 | 14 | Renal impairment |
| 127772441 | 12777244 | 15 | Iron deficiency |
| 127772441 | 12777244 | 16 | Asthenia |
| 127772441 | 12777244 | 17 | Diabetes mellitus |
| 127772441 | 12777244 | 19 | Eye disorder |
| 127772441 | 12777244 | 20 | Diabetes mellitus |
| 127772441 | 12777244 | 21 | Cardiac disorder |
| 127772441 | 12777244 | 22 | Acidosis |
| 127772441 | 12777244 | 23 | Thyroid disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127772441 | 12777244 | Acidosis | |
| 127772441 | 12777244 | Fatigue | |
| 127772441 | 12777244 | Injection site pruritus | |
| 127772441 | 12777244 | Nausea | |
| 127772441 | 12777244 | Stomach mass |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127772441 | 12777244 | 1 | 20050601 | 0 | ||
| 127772441 | 12777244 | 2 | 201605 | 0 |